<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04530084</url>
  </required_header>
  <id_info>
    <org_study_id>1290569</org_study_id>
    <nct_id>NCT04530084</nct_id>
  </id_info>
  <brief_title>A Single Center Proof Of Concept Study To Assess Intra And Perioperative Safety Profile Of OMNI Surgical System</brief_title>
  <official_title>A Single Center Proof Of Concept Study To Assess Intra And Perioperative Safety Profile Of OMNI Surgical System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mark Gallardo, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>El Paso Eye Surgeons</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective of this study is to determine the safety and usability of OMNI surgical&#xD;
      system in performing canaloplasty and trabeculotomy. Outcome measures will include 1) adverse&#xD;
      events (intraoperative and perioperative) 2) BCVA 3) Secondary surgical interventions 4) mean&#xD;
      IOP and 5) mean number of hypotensive medications&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 21, 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">August 22, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adverse events (intraoperative and perioperative)</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Best Corrected Visual Acuity (BCVA)</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean intraocular pressure (IOP)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean number of ocular hypotensive medications</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Open Angle Glaucoma</condition>
  <arm_group>
    <arm_group_label>Diagnosed with open angle glaucoma</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OMNI Surgical System</intervention_name>
    <description>Scheduled for canaloplasty and trabeculotomy with or without cataract extraction</description>
    <arm_group_label>Diagnosed with open angle glaucoma</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or female subjects, 22 years or older.&#xD;
&#xD;
          2. Visually significant cataract or pseudophakic with a posterior chamber intraocular&#xD;
             lens (PCIOL)&#xD;
&#xD;
          3. Diagnosed with open angle glaucoma (e.g. primary open angle glaucoma, pigmentary&#xD;
             glaucoma, pseudoexfoliative glaucoma)&#xD;
&#xD;
          4. Scheduled for canaloplasty and trabeculotomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Any other intraocular surgery at the time of canaloplasty and trabeculotomy excepting&#xD;
             cataract surgery for those subjects with cataract.&#xD;
&#xD;
          2. Prior trabeculectomy, other bleb-forming glaucoma surgery (e.g. tube shunt), or&#xD;
             implanted trabecular bypass stents.&#xD;
&#xD;
          3. Any other ocular pathologies that may interfere with the study procedure or be&#xD;
             exacerbated by the OMNI procedure.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mark Gallardo, MD</last_name>
    <phone>(915) 542-0279</phone>
    <email>gallardomark@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>El Paso Eye Surgeons</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79902</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 25, 2020</study_first_submitted>
  <study_first_submitted_qc>August 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2020</study_first_posted>
  <last_update_submitted>August 26, 2020</last_update_submitted>
  <last_update_submitted_qc>August 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>El Paso Eye Surgeons</investigator_affiliation>
    <investigator_full_name>Mark Gallardo, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

